Conversion to a Belatacept Based Immunosuppression Regimen in Renal Transplant Recipients

被引:0
|
作者
Paplaczyk, K. [1 ]
Cunningham, K. [1 ]
D'Agostino, C. [1 ]
Pinelli, D. [1 ]
Schulte, J. [1 ]
Shetty, A. [1 ]
机构
[1] Northwestern Mem Hosp, Chicago, IL 60611 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
116
引用
收藏
页码:439 / 440
页数:2
相关论文
共 50 条
  • [21] Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients
    Divard, Gillian
    Aubert, Olivier
    Debiais-Deschamp, Charlotte
    Raynaud, Marc
    Goutaudier, Valentin
    Sablik, Marta
    Sayeg, Caroline
    Legendre, Christophe
    Obert, Julie
    Anglicheau, Dany
    Lefaucheur, Carmen
    Loupy, Alexandre
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (05): : 628 - 637
  • [22] RATIONALE FOR BELATACEPT LESS-INTENSIVE (LI) REGIMEN IN RENAL TRANSPLANT RECIPIENTS
    Shen, Jinshan
    Gelb, Jeff S.
    Townsend, Robert M.
    Zhou, Zexun
    Pfister, Marc
    Harler, Mary Beth
    Kaul, Sanjeev
    TRANSPLANT INTERNATIONAL, 2011, 24 : 255 - 255
  • [23] Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients
    Wen, X.
    Casey, M. J.
    Santos, A. H.
    Hartzema, A.
    Womer, K. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3202 - 3211
  • [24] Clinical Outcomes of Kidney Transplant Recipients Switched to Belatacept Based Regimen
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    TRANSPLANTATION, 2014, 98 : 456 - 456
  • [25] Comparison of Clinical Outcomes of Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.
    Wen, X.
    Casey, M.
    Santos, A.
    Hartzema, A.
    Womer, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 305 - 305
  • [26] Conversion from cyclosporine to tacrolimus based immunosuppression therapy in renal transplant recipients
    Backman, Lars
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A33 - A33
  • [27] Belatacept Immunosuppression in High Risk Liver Transplant Recipients
    Masters, Brian M.
    Sparkes, Tracy M.
    Hanish, Steven I.
    Potosky, Darryn R.
    Hutson, William R.
    Barth, Rolf N.
    LaMattina, John C.
    TRANSPLANTATION, 2015, 99 : 275 - 276
  • [28] Clinical Outcomes of Kidney Transplant Recipients Switched to Belatacept Based Regimen
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 456 - 456
  • [29] Conversion from cyclosporine to tacrolimus based immunosuppression thrapy in renal transplant recipients
    Backman, Lars A.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 138 - 138
  • [30] Conversion from Calcineurin Inhibitor? to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial
    Budde, Klemens
    Prashar, Rohini
    Haller, Hermann
    Rial, Maria C.
    Kamar, Nassim
    Agarwal, Avinash
    de Fijter, Johan W.
    Rostaing, Lionel
    Berger, Stefan P.
    Djamali, Arjang
    Leca, Nicolae
    Allamassey, Lisa
    Gao, Sheng
    Polinsky, Martin
    Vincenti, Flavio
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (12): : 3252 - 3264